| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/17/2007 | CA2158610C 17-deoxycorticosteroid-21-/o/-carboxylic esters, processes for their preparation and pharmaceuticals containing these compounds |
| 07/17/2007 | CA2145535C Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
| 07/17/2007 | CA2132887C Tricyclic 1-aminoethylpyrrole-derivatives |
| 07/17/2007 | CA2054438C Additives to feminine hygiene products |
| 07/14/2007 | WO2007067613A1 1,2,5-thiazolidine derivatives useful for treating conditions mediated by protein tyrosine phosphatases (ptpase) |
| 07/13/2007 | CA2573879A1 Anti-diarrhea preparations for small domestic animals |
| 07/12/2007 | WO2007079470A2 Therapeutic amine-arylsulfonamide conjugate compounds |
| 07/12/2007 | WO2007079422A2 Enhancement of urogenital function |
| 07/12/2007 | WO2007079406A1 Small molecule inhibitors of pdz interactions |
| 07/12/2007 | WO2007079394A2 Arginine heteromers for topical administration |
| 07/12/2007 | WO2007079390A2 Medicament for topical use |
| 07/12/2007 | WO2007079389A2 Composition and method of use thereof |
| 07/12/2007 | WO2007079293A2 Cancer stem cells and uses thereof |
| 07/12/2007 | WO2007079260A1 Methods for improving the pharmacokinetics of hiv integrase inhibitors |
| 07/12/2007 | WO2007079252A2 Sustained release pharmaceutical compositions |
| 07/12/2007 | WO2007079239A2 Bicyclic nitrogen compounds as modulators of ghrelin receptor and uses thereof |
| 07/12/2007 | WO2007079221A2 Method for treating dry-eye syndrome |
| 07/12/2007 | WO2007079214A2 Prokineticin 2 receptor antagonists |
| 07/12/2007 | WO2007079198A2 Metaxalone formulations and methods for the preparation thereof |
| 07/12/2007 | WO2007079186A2 1, 3-oxazolidin-2-one derivatives useful as cetp inhibitors |
| 07/12/2007 | WO2007079182A1 Methods for treating cutaneous lupus using aminoisoindoline compounds |
| 07/12/2007 | WO2007079180A2 Inhibitors of fatty acid amide hydrolase |
| 07/12/2007 | WO2007079177A2 Novel phytic citrate compounds and process for preparing the same |
| 07/12/2007 | WO2007079173A2 Novel 2-heteroaryloxy-phenol derivatives as antibacterial agents |
| 07/12/2007 | WO2007079169A2 Treatment for acute myeloid leukemia |
| 07/12/2007 | WO2007079146A1 Treatment for non-hodgkin's lymphoma |
| 07/12/2007 | WO2007079139A2 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 07/12/2007 | WO2007079128A1 Na+, k+-atpase expression in cervical dysplasia and cancer |
| 07/12/2007 | WO2007079086A1 Pyrazoloalkyl substituted imidazo ring compounds and methods |
| 07/12/2007 | WO2007079078A1 Diamine derivatives as inhibitors of leukotriene a4 hydrolase |
| 07/12/2007 | WO2007079051A2 Application methods to rapidly alter disease and injury states using molecular transport of b6 |
| 07/12/2007 | WO2007079010A2 Carbonates of fenicol antibiotics |
| 07/12/2007 | WO2007079000A2 Kit comprising an osmotic laxative and a stimulant laxative for prepariing the colon for virtual colonoscopy |
| 07/12/2007 | WO2007078990A2 Modified lysine-mimetic compounds |
| 07/12/2007 | WO2007078874A2 Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors |
| 07/12/2007 | WO2007078848A2 Preparation of pharmaceutical salts of 3-o-(3',3'-dimethlsuccinyl) betulinic acid |
| 07/12/2007 | WO2007078839A2 Compounds, compositions and methods |
| 07/12/2007 | WO2007078815A2 Certain chemical entities, compositions, and methods |
| 07/12/2007 | WO2007078808A2 Method for isolating (r)-tofisopam |
| 07/12/2007 | WO2007078796A2 Topical administration carrier composition and therapeutic formulations comprising same |
| 07/12/2007 | WO2007078726A2 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin |
| 07/12/2007 | WO2007078679A2 Practical, cost-effective synthesis of ubiquinones |
| 07/12/2007 | WO2007078618A2 Treatment of pain with 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2(1h)-quinolone or salt thereof |
| 07/12/2007 | WO2007078523A2 5-phenyl-3-benzyl-0xaz0lidin-2-0ne derivatives and related compounds as metabotropic glutamate receptor potentiators for the treatment of neurological and psychiatric disorders |
| 07/12/2007 | WO2007078340A2 Boron-containing small molecules |
| 07/12/2007 | WO2007078335A2 Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation |
| 07/12/2007 | WO2007078279A2 Injectable bone cement |
| 07/12/2007 | WO2007078271A2 Lansoprazole orally disintegrating tablets |
| 07/12/2007 | WO2007078251A1 Compounds |
| 07/12/2007 | WO2007078110A1 Pharmaceutical formulation containing amlodipine and aspirin |
| 07/12/2007 | WO2007077995A1 Muscle-building agent |
| 07/12/2007 | WO2007077990A1 Drug delivery material |
| 07/12/2007 | WO2007077961A2 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands |
| 07/12/2007 | WO2007077949A1 Heterocyclic janus kinase 3 inhibitors |
| 07/12/2007 | WO2007077929A1 Therapeutic agent for metabolic syndrome and food containing the therapeutic agent |
| 07/12/2007 | WO2007077893A1 Therapeutic agent for liver disease and hepatic function-ameliorating agent |
| 07/12/2007 | WO2007077876A1 Novel trihalomethionine derivative and pharmaceutical product containing same |
| 07/12/2007 | WO2007077861A1 NF-κB INHIBITOR |
| 07/12/2007 | WO2007077818A1 Asymmetric reduction method |
| 07/12/2007 | WO2007077806A1 Pharmaceutical composition for application to nail |
| 07/12/2007 | WO2007077783A1 Composition for soft contact lens and adsorption suppressing method |
| 07/12/2007 | WO2007077770A1 Alkylresorcinol glycoside, process for production of the same, and use of the same |
| 07/12/2007 | WO2007077741A1 Transdermally absorbable preparation |
| 07/12/2007 | WO2007077656A1 Liquid medicine for internal use |
| 07/12/2007 | WO2007077573A1 Antimicrobial composition containing triclosan and at least one functionalized hydrocarbon |
| 07/12/2007 | WO2007077541A2 Cosmetic composition comprising glaucine and its use |
| 07/12/2007 | WO2007077528A1 Irradiated compositions and treatment of cancers with radiation in combination with taurolidine and/or taurultam |
| 07/12/2007 | WO2007077510A2 Muscarinic receptor antagonists |
| 07/12/2007 | WO2007077508A2 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors |
| 07/12/2007 | WO2007077490A2 Bicyclic heteroaryl compounds as pde10 inhibitors |
| 07/12/2007 | WO2007077479A1 Spiro-1,2,4-trioxanes as antimalarial agents |
| 07/12/2007 | WO2007077469A1 Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis |
| 07/12/2007 | WO2007077457A2 Treatment of equine laminitis with 5-ht1b/ 1d antagonists |
| 07/12/2007 | WO2007077445A1 Method of diagnosis of a predisposition to laminitis |
| 07/12/2007 | WO2007077435A1 Pharmaceutical compounds |
| 07/12/2007 | WO2007077394A1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
| 07/12/2007 | WO2007077339A1 Interfering rnas targeting the morbillivirus nucleoprotein gene |
| 07/12/2007 | WO2007077329A2 New association of a sinus current if inhibitor and a calcic inhibitor, and pharmaceutical compositions containing the same |
| 07/12/2007 | WO2007077327A1 Association of a sinus current inhibitor if and a conversion enzyme inhibitor |
| 07/12/2007 | WO2007077313A1 Novel heterocyclic oxime derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| 07/12/2007 | WO2007077309A1 Combination comprising combretastatin and anticancer agents |
| 07/12/2007 | WO2007077279A1 Compounds having neuroprotective properties |
| 07/12/2007 | WO2007077276A1 Use of thioproline in body weight reduction treatments |
| 07/12/2007 | WO2007077252A1 Concentrated liquid thyroid hormone composition |
| 07/12/2007 | WO2007077219A1 Amorphous telithromycin compound |
| 07/12/2007 | WO2007077203A2 Triterpenequinone and triterpenephenol derivatives and their application for the treatment of tumors and parasitic diseases |
| 07/12/2007 | WO2007077186A1 Pdf inhibitors |
| 07/12/2007 | WO2007077164A1 New pharmaceutical compositions based on anticholinergics and andolast |
| 07/12/2007 | WO2007077162A1 Use of tiotropium salts in the treatment of moderate persistent asthma |
| 07/12/2007 | WO2007077159A1 Imidazo (1,2-a)pyridin-3-yl-acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof |
| 07/12/2007 | WO2007077158A1 Pharmaceutical compositions for the eradication of helicobacter pylori |
| 07/12/2007 | WO2007077135A1 Pharmaceutical composition containing montelukast |
| 07/12/2007 | WO2007077122A1 Indol-3-yl-carbonyl-spiro-piperidine derivatives |
| 07/12/2007 | WO2007077039A1 Clleasing composition |
| 07/12/2007 | WO2007077005A1 3 , 5-substitγued piperidine compounds as renin inhibitors |
| 07/12/2007 | WO2007077004A1 Macrocyclic compounds useful as bace inhibitors |
| 07/12/2007 | WO2007076875A2 Compounds acting on the serotonin transporter |
| 07/12/2007 | WO2007076709A1 Tri-substituted 1h-imidazolyl compounds, preparation methods, pharmaceutical compositions and pharmaceutical uses thereof |
| 07/12/2007 | WO2007076704A1 Aryl dihydro-naphthalene compounds, their preparation and their use as akt inhibitor for the prevention and treatment of cancer |
| 07/12/2007 | WO2007076699A1 Pharmaceutical composition containing chenopodium ambrosioides extract and its preparing process and application |